2nd Covalent Drug Discovery and Development Summit
Evvnt Promotion / evvnt
10.12.2024 - 12.12.2024 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Temas de la conferencia
Uniting Large Pharma, Innovative Biotech and Leading Academics to Eliminate the Boundaries of Druggability with Novel Covalent Drugs
With continued advancements in screening platforms and proteomics, the covalency renaissance continues as biopharma race to unlock hard-to-target proteins across oncology, immunology and CNS. We are witnessing this industry make great strides in utilizing novel covalent modalities and elucidating novel warheads to target amino acids beyond cysteine.
Uniting Large Pharma, Innovative Biotech and Leading Academics to Eliminate the Boundaries of Druggability with Novel Covalent Drugs
With continued advancements in screening platforms and proteomics, the covalency renaissance continues as biopharma race to unlock hard-to-target proteins across oncology, immunology and CNS. We are witnessing this industry make great strides in utilizing novel covalent modalities and elucidating novel warheads to target amino acids beyond cysteine.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/2537785-3?pid=4832
Speakers: Adam Cotton -Associate - Novartis Venture Fund, Andrea Zuhl -Vice President, Chemical Biology and Proteomics - HYKU Biosciences, and more
URL:
Brochure: https://go.evvnt.com/2537785-3?pid=4832
Speakers: Adam Cotton -Associate - Novartis Venture Fund, Andrea Zuhl -Vice President, Chemical Biology and Proteomics - HYKU Biosciences, and more
Información e inscripción:
https://go.evvnt.com/2537785-2?pid=4832
Ms. Rosie Andre
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
